ConductScience.org, home

Paper36860655

Landscape of Genetic Alterations Underlying Hallmark Signature Changes in Cancer Reveals TP53 Aneuploidy-driven Metabolic Reprogramming.

McClure MB and 11 others. Cancer Res Commun, 2023. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Landscape of Genetic Alterations Underlying Hallmark Signature Changes in Cancer Reveals TP53 Aneuploidy-driven Metabolic Reprogramming. Papers, record 36860655. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36860655

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Landscape of Genetic Alterations Underlying Hallmark Signature Changes in Cancer Reveals TP53 Aneuploidy-driven Metabolic Reprogramming.
PubMed
Journal
Cancer Res Commun
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
1.23
iCite
Revised in PubMed
2026-07-26
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Carcinoma, Squamous CellMajor topic
Humans
Mice
Animals
Female
Tumor Suppressor Protein p53
Mutation
Aneuploidy

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 ES010126NIEHS NIH HHSUnited StatesP30ES010126PubMedNIH RePORTER
R01 CA148761NCI NIH HHSUnited StatesR01CA148761PubMed and NIHNIH RePORTER
P50 CA058223NCI NIH HHSUnited StatesP50CA058223PubMedNIH RePORTER
P20 CA233307NCI NIH HHSUnited StatesP20CA233307PubMed and NIHNIH RePORTER
R01 MD013452NIMHD NIH HHSUnited StatesR01MD013452PubMed and NIHNIH RePORTER

Download CSV of grants

References58

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131068700Next-generation characterization of the Cancer Cell Line Encyclopedia.Nature2019https://conductscience.org/library/papers/31068700PubMed
229448085Plk2 Loss Commonly Occurs in Colorectal Carcinomas but not Adenomas: Relationship to mTOR Signaling.Neoplasia2018https://conductscience.org/library/papers/29448085PubMed
323539594Cancer genome landscapes.Science2013https://conductscience.org/library/papers/23539594PubMed
428622513Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma.Cell2017https://conductscience.org/library/papers/28622513PubMed
527634447Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?Nat Rev Cancer2016https://conductscience.org/library/papers/27634447PubMed
628988769Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.Cell2017https://conductscience.org/library/papers/28988769PubMed
728162975Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.Cancer Cell2017https://conductscience.org/library/papers/28162975PubMed
830635634TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups.Leukemia2019https://conductscience.org/library/papers/30635634PubMed
929625048Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.Cell2018https://conductscience.org/library/papers/29625048PubMed
1022522925The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.Nature2012https://conductscience.org/library/papers/22522925PubMed
1135156101Tumor suppressor PLK2 may serve as a biomarker in triple-negative breast cancer for improved response to PLK1 therapeutics.Cancer Res Commun2021https://conductscience.org/library/papers/35156101PubMed
1225109877Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin.Cell2014https://conductscience.org/library/papers/25109877PubMed
1327653561Toward a Shared Vision for Cancer Genomic Data.N Engl J Med2016https://conductscience.org/library/papers/27653561PubMed
1428187443Analysis of The Cancer Genome Atlas sequencing data reveals novel properties of the human papillomavirus 16 genome in head and neck squamous cell carcinoma.Oncotarget2017https://conductscience.org/library/papers/28187443PubMed
1531068703The landscape of cancer cell line metabolism.Nat Med2019https://conductscience.org/library/papers/31068703PubMed
1626536169Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.N Engl J Med2016https://conductscience.org/library/papers/26536169PubMed
1721527027GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers.Genome Biol2011https://conductscience.org/library/papers/21527027PubMed
1829625053Comprehensive Characterization of Cancer Driver Genes and Mutations.Cell2018https://conductscience.org/library/papers/29625053PubMed
1929622463Genomic and Functional Approaches to Understanding Cancer Aneuploidy.Cancer Cell2018https://conductscience.org/library/papers/29622463PubMed
2012829800Repeated observation of breast tumor subtypes in independent gene expression data sets.Proc Natl Acad Sci U S A2003https://conductscience.org/library/papers/12829800PubMed

See all 58 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
42225967TP53 deficiency in AML induces resistance to T-cell engagers through an immunosuppressive secretome.Leukemia2026https://conductscience.org/library/papers/42225967PubMed
41674841Concurrent Germline-Somatic Alterations and Associations with Cancer Outcomes: A Systematic Review of Concurrent Data Use.Res Sq2026https://conductscience.org/library/papers/41674841PubMed
41133008TTF-1 and p40 co-expression defines a distinct subtype of non-small cell lung cancer with frequent TP53 mutations and FGFR pathway dysregulation.Transl Lung Cancer Res2025https://conductscience.org/library/papers/41133008PubMed
40565062Metabolic Reprogramming of Urothelial Carcinoma-A Theragnostic Target for Betulinic Acid.Int J Mol Sci2025https://conductscience.org/library/papers/40565062PubMed
40333415The Hallmarks of Aneuploidy in Cancer and Congenital Syndromes.Annu Rev Genomics Hum Genet2025https://conductscience.org/library/papers/40333415PubMed
39885167Understanding metastasis mixed-treatment responses through genomic analyses.NPJ Breast Cancer2025https://conductscience.org/library/papers/39885167PubMed
39725169Interferon Epsilon Loss Is Elusive 9p21 Link to Immune-Cold Tumors, Resistant to Immune Checkpoint Therapy, and Endogenous CXCL9/10 Induction.J Thorac Oncol2025https://conductscience.org/library/papers/39725169PubMed
39493875PhosCancer: A comprehensive database for investigating protein phosphorylation in human cancer.iScience2024https://conductscience.org/library/papers/39493875PubMed
39405607Role of glucose metabolic reprogramming in colorectal cancer progression and drug resistance.Transl Oncol2024https://conductscience.org/library/papers/39405607PubMed
39161899Impact of p53-associated acute myeloid leukemia hallmarks on metabolism and the immune environment.Front Pharmacol2024https://conductscience.org/library/papers/39161899PubMed
38924459Patterns of Aneuploidy and Signaling Consequences in Cancer.Cancer Res2024https://conductscience.org/library/papers/38924459PubMed
38688924Molecular profiling of a bladder cancer with very high tumour mutational burden.Cell Death Discov2024https://conductscience.org/library/papers/38688924PubMed

Download CSV of cited by

Genes14

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36860655

GET https://conductscience.org/api/papers/v1/36860655/references?page=2